First foreign e-commerce provider gets internet drug information certificate

Recently, an online shopping mall named “LeCoolsky”, which was unfathomable in the previous wave of medical e-commerce, received the “Internet Drug Information Service Qualification Certificate” approved and issued by the Food and Drug Administration. This was a joint venture between Baidu and Japan Lotto in early 2010. 50 million US dollars was established, of which Loti accounted for 51% of the shares, Baidu accounted for 49%. This is also the first foreign e-commerce company involved in China's online pharmaceutical business.

Together with Tencent, Taobao Mall, and Jingdong (Weibo), which had previously obtained the certificate, e-commerce companies that have become inept in traditional industries such as 3C and books have already begun to burn the war on the pharmaceutical industry.

However, major e-commerce predators are still waiting for the arrival of medical network transactions in spring.

Medicine B2C looks beautiful

Many giants of the Chinese Internet have gathered in e-commerce for medicine, but the picture is just one of them. According to data released by the China Pharmaceutical Business Association, China's pharmaceutical retail market was 173.9 billion yuan in 2010, and China’s network sales have just exceeded 100 million yuan. In contrast, in 2010, the US retail drug network reached US$170 billion, accounting for nearly 30% of the overall pharmaceutical retail sales. The future of medicine in the B2C field has great potential.

In an interview with a reporter from the Southern Capital Department, Health Club CEO Su Zhan said that at present, the entire society is under the general background of sub-health and aging, and the general trend of the entire pharmaceutical industry is continuously developing. He estimated that the market's annual growth rate. It can reach about 20%. In addition to the growth of medicine, B2C medicines can also enjoy the bonuses brought about by the growth of online sales itself, thus forming a compound growth.

B2C drug trading threshold high

However, it is not easy for e-commerce companies to sell drugs on the Internet legally. First, the policy threshold is high. Obtaining the Internet Drug Information Service Qualification Certificate is only the first step in the Wanli Long March. If you want to sell drugs, you must also pass through the food and drug regulatory authorities. Review and acceptance and obtain the "Internet Drug Trade Service Qualification Certificate."

According to regulations, the “Internet Drug Information Service Qualification Certificate” can only display drug information and must not carry out transactions. However, the provisional regulation does not provide detailed regulations for the cooperation between B2C online pharmacies that have obtained the “two certificates” and other third-party e-commerce platforms to sell drugs. Therefore, Taobao, which only received the Internet Drug Information Service Qualification Certificate, once played a policy and signed contracts with some online pharmacies that had transaction qualifications. Taobao Medical Center was used as a platform for matching transactions, but was quickly stopped by relevant departments.

The enterprises that have successfully obtained two certificates still face two major problems of logistics distribution and reimbursement.

Because of the peculiar nature of medicines, its distribution is different from ordinary products, and logistics must also have GSP qualifications. When the traditional high-volume transport model becomes a small retail distribution model, the scale effect no longer exists, and the logistics cost will suddenly increase. Liu Zhaonian, vice chairman of Kyushu Tong, revealed to reporters that dozens of online drugstores that currently have B2C transaction qualifications are almost all loss-making. Before the operation of the Taobao Mall Medical Museum had relied on social logistics without GSP qualification, trying to reduce costs through this move, but this is actually a violation.

In addition, medical insurance fixed-point qualification is another life portal for medical e-commerce. With the increase in the scope of medicines for medical insurance reimbursement catalogs in recent years, more and more medicines can be reimbursed. However, as far as the current situation is concerned, online pharmacies are less likely to obtain medical insurance qualifications. This has caused e-commerce companies to lose their price advantage and the development of the entire industry has also been constrained.

Medicine B2C or trend

However, in some domestic people who are committed to expanding the B2C business of pharmaceuticals, this is just a setback that will inevitably be encountered in the development of new industries. Drug B2C will be the trend of the times.

According to Su Zhan, "The operation of B2C online pharmacies and online counterfeit drugs are two things. The proliferation of counterfeit drugs requires the relevant departments to strengthen supervision. This is not necessarily linked to online pharmacy operations because the current B2C pharmacies selling drugs online are Have legal qualifications, and the business is more standardized."

Jingdong Mall is a direct share of a good pharmacist online pharmacy, resolutely give up the link with the B2C online pharmacy, only to expand business in a good pharmacist online pharmacy.

Taobao Mall, which was previously investigated, has continued to explore B2C medicine through various methods.

According to industry insiders, e-commerce in the traditional industries are involved in online medicine. This first shows that this industry is increasingly favored by the society. Moreover, these e-commerce companies with sufficient capital and excellent operating capabilities to enter the pharmaceutical B2C, means that the industry There will be a major reshuffle so as to positively promote the development of this industry in the long run.

However, selling drugs is not the same as selling other commodities. The former emphasizes service and refinement, and the price effect is less obvious in other industries. Consumers are more concerned with the effectiveness and safety of drugs. Drug B2C single site must create a more professional sales team, strengthen the professionalism of medical services, and form the core competitiveness.

Cosmetic Ingredient

Cosmetic Ingredient,Popular Cosmetics Ingredients,Standard Cosmetic Ingredient,Cosmetics Ingredients Nature

COFCO HEBEI INTERNATIONAL TRADING CO., LTD. , https://www.cofcohb.com

Posted on